Home   ->   news   ->   Press Releases

Press Releases

WuXi PharmaTech Hailed as China's Biotech Star

August 18, 2005 - Shanghai, China - After operating successfully for the past four years in China's infant biotech industry, Shanghai-based WuXi PharmaTech Co., Ltd. is gaining more and more international publicity. Recently, Red Herring, a weekly magazine for technology entrepreneurs, investors and industry observers, featured a photo of Dr. Ge Li, CEO and founder of WuXi PharmaTech, on the cover of the August 1, 2005 issue. The choice reflects both the shifting focus of the global technology industry to Asia, as well as WuXi PharmaTech as an undisputed leader in the pharmaceutical R&D industry in China.

The cover story, titled "Will Biotech Bloom in China?", introduces China's fast-growing biotech sector. Pushed by the government and spearheaded by a group of ambitious entrepreneurs, China's biotech industry is making bounds and strides. Still, the article points out, success stories are few and far between. The article suggests that WuXi PharmaTech can, along with a number of other companies, leverage the country's strengths to develop the biotech ecosystem which is still in its embryonic phase. With the right approach, a large pool of highly skilled, inexpensive scientific talent and low manufacturing costs, WuXi PharmaTech fills the needs of developed biotech markets by providing competitively priced services in many areas of the drug discovery and development process.

The details can be found online at: http://www.redherring.com./Article.aspx?a=12930&hed=Biotech+Blooms+in+China.

About WuXi PharmaTech (Cayman) Inc. WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.

back to top